Hydrocephalus medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Hydrocephalus}} {{CMG}}; __NOTOC__'''Associate Editor-In-Chief:''' Cafer Zorkun M.D., PhD.,{{KD}} ==Medical Therapy== '''Carbonic anhydrase inhibitor:''' [[...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}}; __NOTOC__'''Associate Editor-In-Chief:''' [[User:zorkun|Cafer Zorkun]] M.D., PhD.,{{KD}} | {{CMG}}; __NOTOC__'''Associate Editor-In-Chief:''' [[User:zorkun|Cafer Zorkun]] M.D., PhD.,{{KD}} | ||
==Medical Therapy== | ==Medical Therapy== | ||
'''Carbonic anhydrase inhibitor | '''[[Carbonic anhydrase inhibitor]]''': [[Acetazolamide]] may provide temporary releif by reducing the rate of CSF production, but long term results are disappointing. | ||
'''[[Diuretics]]''':[[Furosemide]] can be used as an adjunctive therapy with acetazolamide. | '''[[Diuretics]]''': [[Furosemide]] can be used as an adjunctive therapy with acetazolamide. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 02:49, 23 July 2012
|
Hydrocephalus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hydrocephalus medical therapy On the Web |
|
American Roentgen Ray Society Images of Hydrocephalus medical therapy |
|
Risk calculators and risk factors for Hydrocephalus medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun M.D., PhD.,Kalsang Dolma, M.B.B.S.[2]
Medical Therapy
Carbonic anhydrase inhibitor: Acetazolamide may provide temporary releif by reducing the rate of CSF production, but long term results are disappointing.
Diuretics: Furosemide can be used as an adjunctive therapy with acetazolamide.